Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hyperlipoproteinemias

Free Subscription Articles published in PLoS One Retrieve available abstracts of 38 articles: HTML format

Single Articles

January 2025
1. MIAO X, Li B, Zhu Z, Yang T, et al
   Sex differences in the association between composite dietary antioxidant index and hyperlipidemia: Insights from NHANES.
   PLoS One. 2025;20:e0316130.
   PubMed     Abstract available
   
   
   
2. RASOOL A, Chidi C, Rigaut S, Carty S, et al
   A novel combinatorial approach integrating experimental and computational analysis of antioxidant activity: Evaluating catechin and L-ascorbic acid in serum.
   PLoS One. 2025;20:e0309881.
   PubMed     Abstract available
   
   
   
3. YE R, Huang X, Yang H, Pan W, et al
   A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes.
   PLoS One. 2025;20:e0315781.
   PubMed     Abstract available
   
   
   
4. LI M, Hu X, Hu X, Gao F, et al
   Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling.
   PLoS One. 2025;20:e0320509.
   PubMed     Abstract available
   
   
   
5. SU Z, Ling Z, Chen H, Hu L, et al
   Association between hyperlipidemia and nephrolithiasis: A comprehensive bioinformatics analysis deciphering the potential common denominator pathogenesis.
   PLoS One. 2025;20:e0321734.
   PubMed     Abstract available
   
   
   
6. SHI F, Yang D, Sun Q, Fang C, et al
   Association of the newly proposed dietary index for gut microbiota and hyperlipidemia: From the 2007-2020 NHANES study.
   PLoS One. 2025;20:e0323887.
   PubMed     Abstract available
   
   
   
7. KADDUMUKASA M, Kaddumukasa M, Mbalinda SN, Najjuma J, et al
   A 6-month, prospective randomized controlled trial of the TargetEd MAnageMent (TEAM) intervention vs. enhanced treatment as usual among Ugandans at risk for stroke.
   PLoS One. 2025;20:e0330606.
   PubMed     Abstract available
   
   
   
8. ABBAS G, Malik MNH, Yasin H, Alshammari SO, et al
   Charantin targets HMGCR-PCSK9 axis and activates PPAR-alpha signaling to ameliorate hyperlipidemia: Mechanistic insights from bioinformatics and in-vivo studies.
   PLoS One. 2025;20:e0331356.
   PubMed     Abstract available
   
   
   
9. BEKKOUCH O, Bekkouch A, Elbouny H, Touiss I, et al
   Combinatorial effects of Zingiber officinale and Citrus limon juices: Hypolipidemic and antioxidant insights from in vivo, in vitro, and in silico investigations.
   PLoS One. 2025;20:e0319721.
   PubMed     Abstract available
   
   
   January 2024
10. ALBASSAM AA, Alenzi AN, Alhaqbani NK, Alhouty FK, et al
    Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases-A cross-sectional insight from Alkharj, Saudi Arabia.
    PLoS One. 2024;19:e0295116.
    PubMed     Abstract available
    
    
    
11. ABD RAHIM IN, Mohd Kasim NA, Omar E, Abdul Muid S, et al
    Safety evaluation of saffron extracts in early and established atherosclerotic New Zealand white rabbits.
    PLoS One. 2024;19:e0295212.
    PubMed     Abstract available
    
    
    
12. LI Y, Gao H, Zhao J, Ma L, et al
    Safety and efficacy of bempedoic acid among patients with statin intolerance and those without: A meta-analysis and a systematic randomized controlled trial review.
    PLoS One. 2024;19:e0297854.
    PubMed     Abstract available
    
    
    
13. XU S, Shiomi H, Yamashita Y, Koyama S, et al
    CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.
    PLoS One. 2024;19:e0297231.
    PubMed     Abstract available
    
    
    
14. GHANEM AS, Nemeth O, More M, Nagy AC, et al
    Role of oral health in heart and vascular health: A population-based study.
    PLoS One. 2024;19:e0301466.
    PubMed     Abstract available
    
    
    
15. YAZDANI A, Mozaffarpur SA, Ebrahimi P, Shirafkan H, et al
    Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
    PLoS One. 2024;19:e0301209.
    PubMed     Abstract available
    
    
    
16. GUO L, Zhao P, Xue S, Zhu Z, et al
    Association of urinary bisphenol A with hyperlipidemia and all-cause mortality: NHANES 2003-2016.
    PLoS One. 2024;19:e0304516.
    PubMed     Abstract available
    
    
    
17. LIN YW, Chen PC, Lin CH, Lin MH, et al
    Investigating medication adherence among Taiwanese patient with hypertension, hyperlipidemia, and diabetes: A pilot study using the Chinese version of a Two-Part Medication Nonadherence Scale and the NHI MediCloud system.
    PLoS One. 2024;19:e0304442.
    PubMed     Abstract available
    
    
    
18. 
    Correction: Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2024;19:e0307980.
    PubMed     Abstract available
    
    
    
19. ZHUANG Y, Wang Y, Sun P, Ke J, et al
    Association between blood lead, cadmium, selenium levels and hyperlipidemia: A population-based study.
    PLoS One. 2024;19:e0306573.
    PubMed     Abstract available
    
    
    
20. HU YN, Wu M, Yu HP, Wu QY, et al
    Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia.
    PLoS One. 2024;19:e0310547.
    PubMed     Abstract available
    
    
    
21. ASADI-ALIABADI M, Karimi SM, Mirbaha-Hashemi F, Tehrani-Banihashemi A, et al
    The effect of results-based motivating system on metabolic risk factors of non-communicable diseases: A field trial study.
    PLoS One. 2024;19:e0311507.
    PubMed     Abstract available
    
    
    
22. ZHAO M, Zhang Q, Lin Y, Zhang D, et al
    The association between dietary carbohydrate intake and the risk of hyperlipidemia among reproductive-aged women in the US: A cross-sectional study.
    PLoS One. 2024;19:e0310184.
    PubMed     Abstract available
    
    
    
23. LIU L, Deng Y, Li L, Yang X, et al
    Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
    PLoS One. 2024;19:e0310696.
    PubMed     Abstract available
    
    
    
24. BAKER LA, Minor KM, Tate N, Furrow E, et al
    Whole blood gene expression analysis of spontaneous hypertriglyceridemia in dogs suggests an underlying pro-thrombotic process.
    PLoS One. 2024;19:e0313343.
    PubMed     Abstract available
    
    
    
25. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    PubMed     Abstract available
    
    
    
26. BLOKHINA AV, Ershova AI, Kiseleva AV, Sotnikova EA, et al
    Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.
    PLoS One. 2024;19:e0315693.
    PubMed     Abstract available
    
    
    
27. YANG T, Li W, Chen W, Zhu D, et al
    Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.
    PLoS One. 2024;19:e0312588.
    PubMed     Abstract available
    
    
    January 2023
28. ALAHMAD MM, ZainAlAbdin S, AlAhmad K, AlAhmad I, et al
    Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management.
    PLoS One. 2023;18:e0283369.
    PubMed     Abstract available
    
    
    
29. SONG DK, Hong YS, Sung YA, Lee H, et al
    The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.
    PLoS One. 2023;18:e0283393.
    PubMed     Abstract available
    
    
    
30. SAPKOTA BP, Baral KP, Rehfuess EA, Parhofer KG, et al
    Effects of age on non-communicable disease risk factors among Nepalese adults.
    PLoS One. 2023;18:e0281028.
    PubMed     Abstract available
    
    
    
31. CHANG KC, Pai YW, Lin CH, Lee IT, et al
    The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0287373.
    PubMed     Abstract available
    
    
    
32. CHEN PT, Zhang HW, Tsai ZR, Peng HC, et al
    Association between hyperlipidemia and trigger finger: A nationwide population-based cohort study.
    PLoS One. 2023;18:e0288426.
    PubMed     Abstract available
    
    
    
33. VAINSHELBOIM B, Myers J
    Dyslipidemia paradox: Analysis from the veterans exercise testing study.
    PLoS One. 2023;18:e0287923.
    PubMed     Abstract available
    
    
    
34. HEERKENS L, van Kleef LA, de Knegt RJ, Voortman T, et al
    Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
    PLoS One. 2023;18:e0287467.
    PubMed     Abstract available
    
    
    
35. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    PubMed     Abstract available
    
    
    
36. BADACHO AS, Mahomed OH
    Mapping evidence on barriers to and facilitators of diagnosing noncommunicable diseases (NCDs) among people living with human immunodeficiency virus (PLWH) in low- and middle-income countries (LMICs) in Africa: A scoping review protocol.
    PLoS One. 2023;18:e0294979.
    PubMed     Abstract available
    
    
    
37. FU W, Hu F, Xu C
    Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
    PLoS One. 2023;18:e0296019.
    PubMed     Abstract available
    
    
    January 2021
38. DIECI M, Llibre-Rodriguez JJ, Acosta D, Dow WH, et al
    Cuba's cardiovascular risk factors: International comparison of levels and education gradients.
    PLoS One. 2021;16:e0247831.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.